Cargando…
The Delayed-Release Combination of Doxylamine and Pyridoxine (Diclegis(®)/Diclectin(®)) for the Treatment of Nausea and Vomiting of Pregnancy
Nausea and vomiting of pregnancy (NVP) affects up to 85 % of all pregnancies. Effective treatment can greatly improve a woman’s quality of life, reduce the risk for maternal and fetal complications, and reduce healthcare costs. Unfortunately, many women receive either no pharmacological treatment or...
Autores principales: | Madjunkova, Svetlana, Maltepe, Caroline, Koren, Gideon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030125/ https://www.ncbi.nlm.nih.gov/pubmed/24574047 http://dx.doi.org/10.1007/s40272-014-0065-5 |
Ejemplares similares
-
Doxylamine succinate–pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview
por: Nuangchamnong, Nina, et al.
Publicado: (2014) -
Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy
por: Koren, Gideon, et al.
Publicado: (2016) -
Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial
por: Koren, Gideon, et al.
Publicado: (2015) -
The Leading Concerns of American Women with Nausea and Vomiting of Pregnancy Calling Motherisk NVP Helpline
por: Madjunkova, Svetlana, et al.
Publicado: (2013) -
Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis
por: Persaud, Navindra, et al.
Publicado: (2018)